Souhaitez-vous accéder aux communiqués récents ?

This is a correction of the announcement from 04.05.2020, 16:00 CEST. Reason for the correction: Change of record date and payment date. Dividend amount: NOK 1 Declared currency: NOK Last day...

Dividend amount: NOK 1 Declared currency: NOK Last day including right: 19 May 2020 Ex-date: 20 May 2020 Record date: 21 May 2020 Payment date: Approx. 7 June. Date of approval: 19 May 2020 ...

Oslo, Norway, 4 May 2020 Vistin Pharma ASA (OSE: VISTIN), reference is made to the announcement on 28 April 2020 regarding the annual general meeting to be held on 19 May. Please find attached the...

Oslo, Norway, 28 April 2020 Vistin Pharma ASA (OSE: VISTIN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 19 May at 13:00 CEST.  Due to the Covid-19...

Oslo, 23 April 2020 Please find attached the Annual Report for 2019 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full year results...

Oslo, Norway, 23 April 2020 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN), announces that the Board of Directors have approved the investment to install a 2nd production line and double the...

Oslo, Norway, 23 April 2020 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the first quarter of 2020, with a 45% increase in revenue and a record quarterly...

Oslo, Norway, 20 April 2020 Vistin Pharma ASA will release its first quarter 2020 results on Thursday 23 April 2020. Vistin Pharma will host a conference call for all shareholders and interested...

Oslo, Norway, 30 March 2020 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN), announces that the company has closed all its remaining oil derivatives positions. The company believe...

Oslo, Norway, 9 March 2020 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN), announces that the company has changed its exposure to the spread between ICE low sulphur gasoil and Sing380. The...